SCHEMBL7956397

SCHEMBL7956397

S=C1CCCCN1Cc1ccc(Cl)nc1

nearest known ligand 0.73

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
CHRNA7 P36544 4/20 0.56
CHRNA1 P02708 3/20 0.56
CHRNA3 P32297 2/20 0.56
CHRNB2 P17787 1/20 0.56
CHRNA4 P43681 1/20 0.56
ALDH1A1 P00352 2/20 0.54
SMN1; SMN2 Q16637 1/20 0.50
MEN1 O00255 1/20 0.48
KMT2A Q03164 1/20 0.48
TDP1 Q9NUW8 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17479608 0.98 CHRNA7 (0.55) CHRNA7CHRNA1CHRNA3CHRNB2CHRNA4
SCHEMBL7961750 0.97 CHRNA7 (0.56) CHRNA7CHRNA1CHRNA3CHRNB2CHRNA4
SCHEMBL7497453 0.84 CHRNA7 (0.59) CHRNA7CHRNA1CHRNA3CHRNB2CHRNA4
SCHEMBL7956805 0.84 L3MBTL1 (0.60) CHRNA7CHRNA1CHRNA3CHRNB2CHRNA4
SCHEMBL17479542 0.83 L3MBTL1 (0.63) CHRNA7CHRNA1CHRNA3CHRNB2CHRNA4
SCHEMBL7503846 0.81 CHRNA7 (0.59) CHRNA7CHRNA1CHRNA3CHRNB2CHRNA4
SCHEMBL938032 0.81 L3MBTL1 (0.56) CHRNA7CHRNA1CHRNA3CHRNB2CHRNA4
SCHEMBL6330457 0.81 CHRNA7 (0.62) CHRNA7CHRNA1CHRNA3CHRNB2CHRNA4
SCHEMBL1823298 0.80 KMT2A (0.63) CHRNA7CHRNA1CHRNA3CHRNB2CHRNA4
SCHEMBL4592427 0.78 HRH3 (0.64) ALDH1A1SMN1; SMN2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016016131-A1 PESTICIDALLY ACTIVE CYCLIC ENAMINONES SYNGENTA PARTICIPATIONS AG (CH) 2016-02-04 WO disclosed
WO-2016016131-A1 PESTICIDALLY ACTIVE CYCLIC ENAMINONES SYNGENTA PARTICIPATIONS AG (CH) 2016-02-04 WO disclosed
US-6303638-B1 FOR THERAPY OF CENTRAL NERVOUS SYSTEM (CNS) DISORDERS, INCLUDING ALZHEIMER'S DISEASE, TOURETTE'S SYNDROME, COGNITIVE DYSFUNCTION E.G., DISORDERS OF ATTENTION, FOCUS AND CONCENTRATION, SUCH AS ATTENTION DEFICIT DISORDER THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2001-10-16 US disclosed